Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

NYMX 0.614 -0.016 (-2.59%)
price chart
Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation ...
PHILADELPHIA, Nov. 26, 2014 /PRNewswire/ -- Cohen, Placitella & Roth, PC is investigating potential claims on behalf of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") NYMX, +50.55% during the period from January ...
Related articles »  
Class Action Lawsuit Filed Against Nymox Pharmaceutical Corporation and Paul ...
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Law Offices Bernard M. Gross, P.C. filed a class action lawsuit in the United States District Court, District of New Jersey, 14-cv-07331, on behalf of purchasers of NYMOX common stock between January ...
Related articles »  
Here's Why Nymox Nosedived Yesterday
Nymox is a biopharmaceutical that focuses on the development of novel therapeutics for the aging population. The company already has two products in the market - both being at-home tests. The first, called NicAlert, is used to test a person's smoking ...
Nymox Pharma (NYMX) Phase 3 Studies of NX-1207 Fail to Meet Primary ...  StreetInsider.com (subscription)
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 ...  GlobeNewswire (press release)
Related articles »  
Rosen Law Firm Reminds Nymox Pharmaceutical Corporation Investors of ...
NEW YORK, Jan. 12, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq:NYMX) during the period from January 31, 2011 through November 2, 2014, of the important January ...
Share Price of Nymox Pharmaceutical Corporation Rally 56.1%
Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) rose by 56.1% in the past week and 64.1% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 56.53% and the outperformance increases to 55.56% for the last ...
Closing Bell Reports: Nymox Pharmaceutical Corporation (NYMX), Discovery ...  WallStreet Scope
Micro Cap Stocks in the Spotlight - Emerald Oil (EOX), Nymox Pharmaceutical ...  Techsonian (press release)
Nymox Pharmaceutical Corporation Short Interest Update
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported a shortfall of 33,281 shares or 3.6% in the short interest. The remaining shorts are 3.7% of the total floated shares.
Mid-Day Changers: Nymox Pharmaceutical Corporation (NYMX), Clean Energy ...  WallStreet Scope
Robbins Arroyo LLP: Nymox Pharmaceutical Corporation (NYMX) Misled ...
SAN DIEGO and QUEBEC, Canada, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Nymox Pharmaceutical Corporation (Nasdaq:NYMX) has filed a federal securities fraud class action ...
Related articles »  
EQUITY ALERT: Rosen Law Firm Reminds Nymox Pharmaceutical Corporation ...
NEW YORK, Dec. 12, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq:NYMX) during the period from January 31, 2011 through November 2, 2014, of the important ...
Related articles »  
Stocks with High Volume: Nymox Pharmaceutical Corp , Sinclair Broadcast ...
Nymox Pharmaceutical Corp (NYMX) has dropped 18.1924% or 0.1401 points in todays trading session. The shares opened at 0.899 with the volume touching 1,800,809 shares, the last trade was executed at 0.63.
Stocks to Track-Nymox (NYMX), Bioline (BLRX), Vantage (VTG), DURECT (DRRX)  Techsonian (press release)
Share Price of Nymox Pharmaceutical Corporation Drops by -4.34%
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has lost 4.34% during the past week and dropped 9.13% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 6.24%.